Your browser doesn't support javascript.
loading
Co-degradation of interferon signaling factor DDX3 by PB1-F2 as a basis for high virulence of 1918 pandemic influenza.
Park, Eun-Sook; Byun, Young Ho; Park, Soree; Jang, Yo Han; Han, Woo-Ry; Won, Juhee; Cho, Kyung Cho; Kim, Doo Hyun; Lee, Ah Ram; Shin, Gu-Choul; Park, Yong Kwang; Kang, Hong Seok; Sim, Heewoo; Ha, Yea Na; Jae, Byeongjune; Son, Ahyun; Kim, Paul; Yu, Jieun; Lee, Hye-Min; Kwon, Sun-Bin; Kim, Kwang Pyo; Lee, Seung-Hyun; Park, Yeong-Min; Seong, Baik L; Kim, Kyun-Hwan.
Affiliation
  • Park ES; Department of Pharmacology, Center for Cancer Research and Diagnostic Medicine, IBST, School of Medicine, Konkuk University, Seoul, Korea.
  • Byun YH; KU Open Innovation Center, Konkuk University, Seoul, Korea.
  • Park S; Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea.
  • Jang YH; Vaccine Translational Research Center, Yonsei University, Seoul, Korea.
  • Han WR; Department of Pharmacology, Center for Cancer Research and Diagnostic Medicine, IBST, School of Medicine, Konkuk University, Seoul, Korea.
  • Won J; Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea.
  • Cho KC; Vaccine Translational Research Center, Yonsei University, Seoul, Korea.
  • Kim DH; Department of Pharmacology, Center for Cancer Research and Diagnostic Medicine, IBST, School of Medicine, Konkuk University, Seoul, Korea.
  • Lee AR; Department of Pharmacology, Center for Cancer Research and Diagnostic Medicine, IBST, School of Medicine, Konkuk University, Seoul, Korea.
  • Shin GC; Department of Applied Chemistry, Kyung Hee University, Yongin, Korea.
  • Park YK; Department of Pharmacology, Center for Cancer Research and Diagnostic Medicine, IBST, School of Medicine, Konkuk University, Seoul, Korea.
  • Kang HS; Department of Pharmacology, Center for Cancer Research and Diagnostic Medicine, IBST, School of Medicine, Konkuk University, Seoul, Korea.
  • Sim H; Department of Pharmacology, Center for Cancer Research and Diagnostic Medicine, IBST, School of Medicine, Konkuk University, Seoul, Korea.
  • Ha YN; Department of Pharmacology, Center for Cancer Research and Diagnostic Medicine, IBST, School of Medicine, Konkuk University, Seoul, Korea.
  • Jae B; Department of Pharmacology, Center for Cancer Research and Diagnostic Medicine, IBST, School of Medicine, Konkuk University, Seoul, Korea.
  • Son A; Department of Pharmacology, Center for Cancer Research and Diagnostic Medicine, IBST, School of Medicine, Konkuk University, Seoul, Korea.
  • Kim P; Department of Pharmacology, Center for Cancer Research and Diagnostic Medicine, IBST, School of Medicine, Konkuk University, Seoul, Korea.
  • Yu J; Department of Pharmacology, Center for Cancer Research and Diagnostic Medicine, IBST, School of Medicine, Konkuk University, Seoul, Korea.
  • Lee HM; Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea.
  • Kwon SB; Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea.
  • Kim KP; Vaccine Translational Research Center, Yonsei University, Seoul, Korea.
  • Lee SH; Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea.
  • Park YM; Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea.
  • Seong BL; Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea.
  • Kim KH; Department of Applied Chemistry, Kyung Hee University, Yongin, Korea.
EMBO J ; 38(10)2019 05 15.
Article in En | MEDLINE | ID: mdl-30979777
The multifunctional influenza virus protein PB1-F2 plays several roles in deregulation of host innate immune responses and is a known immunopathology enhancer of the 1918 influenza pandemic. Here, we show that the 1918 PB1-F2 protein not only interferes with the mitochondria-dependent pathway of type I interferon (IFN) signaling, but also acquired a novel IFN antagonist function by targeting the DEAD-box helicase DDX3, a key downstream mediator in antiviral interferon signaling, toward proteasome-dependent degradation. Interactome analysis revealed that 1918 PB1-F2, but not PR8 PB1-F2, binds to DDX3 and causes its co-degradation. Consistent with intrinsic protein instability as basis for this gain-of-function, internal structural disorder is associated with the unique cytotoxic sequences of the 1918 PB1-F2 protein. Infusing mice with recombinant DDX3 protein completely rescued them from lethal infection with the 1918 PB1-F2-producing virus. Alongside NS1 protein, 1918 PB1-F2 therefore constitutes a potent IFN antagonist causative for the severe pathogenicity of the 1918 influenza strain. Our identification of molecular determinants of pathogenesis should be useful for the future design of new antiviral strategies against influenza pandemics.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Orthomyxoviridae / Viral Proteins / Interferons / Influenza, Human / DEAD-box RNA Helicases Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: EMBO J Year: 2019 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Orthomyxoviridae / Viral Proteins / Interferons / Influenza, Human / DEAD-box RNA Helicases Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: EMBO J Year: 2019 Document type: Article Country of publication: